Palantir stock is trading at a lofty valuation "which history suggests is nearly impossible to grow into," Deutsche Bank's ...
You can't spell gains without "AI" In the fourth quarter, Palantir generated revenue that accelerated to 36% year over year ...
Alphabet revenue misses expectations, Robinhood Markets says Super Bowl bets are off, and more news to start your day.
Palantir Technologies (PLTR) blowout financial results weren’t enough to convince analysts at Citigroup (C) that the stock is ...
Palantir shares leaped ~20% higher after recently reporting Q4 results, and more importantly, issuing very bullish guidance ...
Bank of America analysts raised their price target on the stock after earnings, citing Palantir's edge in a crowded market.
Despite impressive profitability and sales growth, PLTR's stock valuation at 53.5x leading sales is frothy, necessitating a ...
Wedbush analyst Daniel Ives raised his Palantir Technologies ( NASDAQ:PLTR) price target to $120 from $90, maintaining a Buy ...
Palantir Technologies (NYSE:PLTR) has been a lightning rod for investor debate over the past few quarters as the stock has ...
Among the 23 analysts who follow Palantir, the median target price of $39 per share implies 62% downside from the current ...
24/7 Wall St. on MSN2h
How to Buy in DeepSeek Stock
Chinese AI lab DeepSeek upended the artificial intelligence market following the release of its R1 large language model. ...
Martin Shkreli, the former hedge fund manager known as "Pharma Bro," defended Palantir Technologies Inc.'s valuation on Tuesday amid the company's surging stock price, projecting substantial cash flow ...